Antiglutamate receptor antibodies and cognitive impairment in primary antiphospholipid syndrome and systemic lupus erythematosus

Frontiers in Immunology

Volumn 7, Issue FEB, 2016, Pages

  Gerosa, Maria ^a,b   Poletti, Barbara ^c   Pregnolato, Francesca ^c   Castellino, Gabriella ^c   Lafronza, Annalisa ^c   Silani, Vincenzo ^a,c   Riboldi, Piersandro ^a,c   Meroni, Pier Luigi ^a,c   Merrill, Joan T ^d  

^a UNIVERSITY OF MILAN   (Italy)

^b ISTITUTO ORTOPEDICO GAETANO PINI   (Italy)

^c ISTITUTO AUXOLOGICO ITALIANO   (Italy)

^d UNIVERSITY OF OKLAHOMA   (United States)

Author keywords

Anti NMDA glutamate receptor antibodies; Antiphospholipid syndrome; Central nervous system involvement; Mild cognitive impairment; Neuropsychological assessment; Systemic lupus erythematosus

Indexed keywords

ANTIGLUTAMATE RECEPTOR ANTIBODY; PHOSPHOLIPID ANTIBODY; RECEPTOR ANTIBODY; UNCLASSIFIED DRUG;

ANTIPHOSPHOLIPID SYNDROME; ARTICLE; BLOOD BRAIN BARRIER; CLINICAL ARTICLE; COGNITIVE DEFECT; CORRELATION ANALYSIS; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; MINI MENTAL STATE EXAMINATION; NONHUMAN; PATHOGENESIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 84962620350     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2016.00005     Document Type: Article

References (24)

1. Lisnevskaia L, Murphy G, Isenberg D. Systemic lupus erythematosus. Lancet (2014) 384:1878-88. doi: 10.1016/S0140-6736(14)60128-8.
2. Miyakis S, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R, et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost (2006) 4:295-306. doi:10.1111/j.1538-7836.2006.01753.x.
3. Meroni PL, Chighizola CB, Rovelli F, Gerosa M. Antiphospholipid syndrome in 2014: more clinical manifestations, novel pathogenic players and emerging biomarkers. Arthritis Res Ther (2014) 16:209. doi:10.1186/ar4549.
4. Hanly JG, Urowitz MB, Su L, Bae SC, Gordon C, Clarke A, et al. Autoantibodies as biomarkers for prediction of neuropsychiatric events in systemic lupus erythematosus. Ann Rheum Dis (2011) 70:1726-32. doi:10.1136/ard.2010.148502.
5. Tektonidou MG, Varsou N, Kotoulas G, Antoniou A, Moutsopoulos HM. Cognitive deficits in patients with antiphospholipid sindrome. Arch Intern Med (2006) 166:2278-84. doi:10.1001/archinte.166.20.2278.
6. Kozora E, Erkan D, Zhang L, Zimmerman R, Ramon G, Ulug AM, et al. Cognitive dysfunction in antiphospholipid antibody (aPL)-negative systemic lupus erythematosus (SLE) versus aPL-positive non-SLE patients. Clin Exp Rheumatol (2014) 32:34-40.
7. Katzav A, Ben-Ziv T, Blank M, Pick CG, Shoenfeld Y, Chapman J. Antibody-specific behavioral effects: intracerebroventricular injection of antiphospholipid antibodies induces hyperactive behavior while anti-ribosomal-P antibodies induces depression and smell deficits in mice. J Neuroimmunol (2014) 204:10-5. doi:10.1016/j.jneuroim.2014.04.003.
8. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 2. Pathogenetic mechanisms of clinical syndromes: a literature investigation. Rheumatology (2002) 41:619-30. doi:10.1093/rheumatology/41.6.619.
9. Hanly JG, Urowitz MB, Siannis F, Farewell V, Gordon C, Bae SC, et al. Autoantibodies and neuropsychiatric events at the time of systemic lupus erythematosus diagnosis. Results from an international inception cohort study. Arthritis Rheum (2008) 58:843-53. doi:10.1002/art.23218.
10. Kowal C, DeGiorgio LA, Lee JY, Edgar MA, Huerta PT, Volpe BT, et al. Human lupus autoantibodies against NMDA receptors mediate cognitive impariment. Proc Natl Acad Sci U S A (2006) 103:1954-9. doi:10.1073/pnas.0608397104.
11. Chang EH, Volpe BT, Mackay M, Aranow C, Watson P, Kowal K, et al. Selective impairment of spatial cognition caused by autoantibodies to the N-methyl-D-aspartate receptor. EBioMedicine (2015) 2:755-64. doi:10.1016/j.ebiom.2015.05.027.
12. Hirohata S, Arinuma Y, Yanagida T, Yoshio T. Blood-brain barrier damages and intrathecal synthesis of anti-N-methyl-D-aspartate receptor NR2 antibodies in diffuse psychiatric/neuropsychological syndromes in systemic lupus erythematosus. Arthritis Res Ther (2014) 16:R77. doi:10.1186/ar4518.
13. DeGiorgio LA, Konstantinov KN, Lee SC, Hardin JA, Volpe BT, Diamond B. A subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med (2001) 7:1189-93. doi:10.1038/nm1101-1189.
14. Kowal C, DeGiorgio LA, Nakaoka T, Hetherington H, Huerta PT, Diamond B, et al. Cognition and immunity; antibody impairs memory. Immunity (2004) 21:179-88. doi:10.1016/j.immuni.2004.07.011.
15. Omdal R, Brokstad K, Waterloo K, Koldingsnes W, Jonsson R, Mellegren SI. Neuropsychiatric disturbances in SLE are associated with antibodies against NMDA receptors. Eur J Neurol (2005) 12:392-8. doi:10.1111/j.1468-1331.2004.00976.x.
16. Lapteva L, Nowak M, Yarboro CH, Takada K, Roebuck-Spencer T, Weickert T, et al. Anti-N-Metyl-D-Aspartate receptor antibodies, cognitive dysfunction, and depression in systemic lupus erythematosus. Arthtritis Rheum (2006) 54:2505-14. doi:10.1002/art.22031.
17. Harrison MJ, Ravdin LD, Lockshin MD. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum (2006) 54:2515-22. doi:10.1002/art.22030.
18. Kozora E, Sterling GW, Maier SF, Filley CM, Arciniegas DB, Brown M, et al. Antibodies against N-methyl-D-aspartate receptors in patients with systemic lupus erythematosus without major neuropsychiatric syndromes. J Neurol Sci (2010) 295:87-91. doi:10.1016/j.jns.2010.04.016.
19. Husebye ES, Sthoeger ZM, Dayan M, Zinger H, Elbirt D, Levite M, et al. Autoantibodies to a NR2A peptide of the glutamate/NMDA receptor in sera of patients with systemic lupus erythematosus. Ann Rheum Dis (2005) 64:1210-3. doi:10.1136/ard.2004.029280.
20. Gono T, Kawaguchi Y, Kaneko H, Nishimura K, Hanaoka M, Kataoka S, et al. Anti-NR2A antibody as a predictor for neuropsychiatric systemic lupus erythematosus. Rheumatology (2011) 50:1578-85. doi:10.1093/rheumatology/keq408.
21. Hanly JG, Su L, Omisade A, Farewell VT, Fisk JD. Screening for cognitive impairment in systemic lupus erythematosus. J Rheumatol (2012) 39:1371-7. doi:10.3899/jrheum.111504.
22. Arinuma Y, Yanagida T, Hirohata S. Association of cerebrospinal fluid anti-NR2 glutamate receptor antibodies with diffuse neuropsychiatric systemic lupus erythematosus. Arthritis Rheum (2008) 58:1130-5. doi:10.1002/art.23399.
23. Yoshio T, Okamoto H, Hirohata S, Minota S. IgG anti-NR2 glutamate receptor autoantibodies from patients with systemic lupus erythematosus activate endothelial cells. Arthritis Rheum (2013) 65:457-63. doi:10.1002/art.37745.
24. Huerta PT, Kowal C, DeGiorgio LA, Volpe BT, Diamond B. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci (2006) 103:678-83. doi:10.1073/pnas.0510055103.